How Long Is Recovery After Stem Cell Therapy?

For most orthobiologic stem cell injections used for joint and musculoskeletal complaints, initial downtime is short. Many patients resume light daily activity within a day or two.

But the biological process the injection is meant to support unfolds over weeks to months, not days (Schneider et al., 2024).

That timeline is different from a hematopoietic (blood-forming) stem cell transplant. This is a separate, FDA-regulated procedure used for certain cancers and blood disorders, and it carries a recovery period measured in months (Cleveland Clinic, 2025).

Which timeline applies to you depends entirely on which procedure you're asking about.

What This Means

If you're picturing a single recovery number, there isn't one.

An outpatient orthobiologic injection into a knee, shoulder, or spine structure is a same-day procedure. Soreness at the injection site typically settles within a few days. Most people are back to routine, non-strenuous activity within 48 to 72 hours (Schneider et al., 2024).

What takes longer is the underlying tissue-repair process the injection is intended to support. This unfolds gradually, often over 4 to 12 weeks for early changes, with continued improvement reported out to several months in some studies (Wang et al., 2026).

A hematopoietic stem cell transplant is a different category of care entirely. It involves conditioning, infusion, and close monitoring. Recovery commonly spans one to several months depending on the type of transplant (Cleveland Clinic, 2025).

Candidacy

Reasonable candidates for an orthobiologic injection are generally adults with a clearly identified musculoskeletal source of pain, confirmed through exam and imaging. They understand the therapy is investigational outside FDA-approved indications and do not expect a guaranteed result.

People typically not appropriate candidates include those with:

• Active infection
• Certain cancers
• Uncontrolled bleeding disorders
• Pregnancy

A licensed physician makes that determination case by case.

Hematopoietic stem cell transplant candidacy is a separate clinical pathway. It is decided by an oncologist or transplant specialist based on the underlying disease, prior therapy, and overall health (Cleveland Clinic, 2025).

Clinical Evaluation

A responsible evaluation starts with identifying the actual source of pain before any procedure is discussed, not the reverse. That typically includes a musculoskeletal and neurological exam, a review of prior imaging, and diagnostic ultrasound when appropriate.

Pain in a joint can come from more than one structure at once. The plan should follow from what's actually generating the symptoms, rather than from a predetermined product.

Available Options

Stem cell injections are one option among several for musculoskeletal pain, not the default. Conventional and mainstream alternatives include:

• Physical therapy
• Activity modification
• Oral or topical anti-inflammatory medication
• Corticosteroid injection
• Platelet-rich plasma (PRP)
• Viscosupplementation
• For more advanced joint disease, surgical options such as arthroscopy or joint replacement

Schneider et al. (2024) reviewed both PRP and stem cell injections. They found each associated with a faster return to daily activity compared with more invasive procedures, though the authors note the evidence base is still developing.

The right option depends on the specific diagnosis, its severity, and the patient's goals, not on which product a clinic happens to sell.

Benefits, Limitations & Risks

Benefits

Reported benefits in the orthobiologic literature include a relatively quick return to daily activity. Some studies also report functional improvement over subsequent months (Wang et al., 2026; Schneider et al., 2024).

Limitations

Real limitations exist alongside that. Outcomes vary by patient, by the specific joint or condition, and by the preparation used. No orthobiologic stem cell product is FDA-approved for musculoskeletal use; it remains investigational in that context (U.S. Food and Drug Administration, n.d.).

Risks

Material risks include injection-site soreness, swelling, and infection. As with any medical procedure, there is also the possibility that the intervention does not produce the improvement a patient was hoping for.

The FDA has separately warned that some clinics market unapproved cell-based products with unsubstantiated claims. It has received reports of serious harm, including infection and tumor formation, tied to unregulated products (U.S. Food and Drug Administration, n.d.).

What the Evidence Shows

What the Evidence Establishes

Current evidence does establish that outpatient orthobiologic injections are generally well tolerated with a short physical downtime. Some randomized controlled trials of mesenchymal stem cell injections for knee osteoarthritis report measurable improvement in pain and function scores compared with control groups (Wang et al., 2026).

What the Evidence Does Not Establish

What the evidence does not yet establish is a single, reliable recovery timeline that applies across patients, conditions, and injection protocols. Protocols and follow-up periods vary widely between studies, and only a fraction of registered trials in this space have been published in peer-reviewed journals.

Evidence also does not currently support broad claims that these injections cure a condition, guarantee pain relief, or reliably prevent disease progression. No reputable source claims otherwise.

Recovery / Next Steps

For a typical outpatient orthobiologic injection, expect soreness for the first few days.

Avoid strenuous exercise and high-impact activity for roughly 2 to 6 weeks, depending on the treatment area and the clinician's protocol.

Expect any functional change to develop gradually over weeks to months rather than immediately (Schneider et al., 2024; Wang et al., 2026).

Report fever, spreading redness, or worsening pain to your provider promptly.

If a hematopoietic stem cell transplant is what you're actually asking about, recovery is longer and more involved. It often takes one to several months with close medical monitoring. Your transplant team will give you a schedule specific to your case (Cleveland Clinic, 2025).

Orlando Considerations

Florida does not have a state law specifically restricting outpatient orthobiologic stem cell injections the way some states regulate other cell-based procedures. This makes physician oversight and a clear pre-procedure evaluation particularly important for Orlando-area patients weighing this option.

Florida's warm, humid climate also makes wound care instructions after any injection worth following closely. Perspiration and outdoor activity can irritate a fresh injection site sooner than in cooler climates.

Frequently Asked Questions

Can I walk the same day as my stem cell injection?

Most patients can walk and resume light activity the same day or the next day, though your clinician may recommend limiting the treated joint for a short period (Schneider et al., 2024).

When will I know if it worked?

Because the underlying biological process is gradual, meaningful change — if it occurs — is typically assessed at follow-up visits over the weeks and months after the procedure, not immediately afterward (Wang et al., 2026).

Is stem cell therapy the same as a bone marrow transplant?

No. Outpatient orthobiologic stem cell injections for joints are a different procedure, with a different regulatory status and a different recovery timeline, than a hematopoietic stem cell (bone marrow) transplant used for cancers and blood disorders (Cleveland Clinic, 2025).

Is stem cell therapy FDA-approved?

The only FDA-approved stem cell products are blood-forming stem cells from umbilical cord blood, used for certain blood and immune disorders. Orthobiologic stem cell injections for joint or musculoskeletal use are not FDA-approved and are considered investigational (U.S. Food and Drug Administration, n.d.).

References

Cleveland Clinic. (2025, March 24). Stem cell (bone marrow) transplant. https://my.clevelandclinic.org/health/treatments/22567-stem-cell-transplants

Mayo Clinic Staff. (2026, January 21). Stem cells: What they are and what they do. Mayo Clinic.

Schneider, N., Sinnott, M., Patel, N., & Joseph, R. (2024, May 9). The use of platelet-rich plasma and stem cell injections in musculoskeletal injuries. Cureus, 16(5), e59970. https://doi.org/10.7759/cureus.59970

U.S. Food and Drug Administration. (n.d.). Important patient and consumer information about regenerative medicine therapies.

Wang, J., Xue, H., Shi, M., & Chen, R. (2026). Mesenchymal stem cell-based therapy for osteoarthritis: A systematic review and meta-analysis of clinical outcomes and functional recovery. Frontiers in Cell and Developmental Biology, 13, Article 1746471.

Last medically reviewed: August 17, 2026.

Related reading

• Do Stem Cell Injections Work?
• How Does Stem Cell Therapy Work?
• Stem Cells and Hearing Loss: What Research Shows

More questions answered on the PrimeCell patient blog, or see frequently asked questions.

Related services at PrimeCell

PrimeCell is a physician-led practice in Orlando. Candidacy for any procedure is determined at an in-person evaluation.